According to our research, we have found expression of miR-183-5p reduced in peripheral blood in patients with diabetic neuropathy, and ITGB1 is one of the targets of miR-183-5p. Therefore, its target should increase, but our research shows a reduced level of this gene.

In your opinion, why ITGB1 decreased in these patients? And is it possible?

Similar questions and discussions